|
|
|
|
|
Video | Thermo Fisher Scientific | Learn how a structured, scalable approach to process development can help improve productivity, maintain product quality, and support a smoother transition to manufacturing. |
|
|
|
Webinar | MaxCyte, Inc. | A critical challenge for therapeutic programs using CRISPR is managing the risk of off-target effects. Evaluate methods to strengthen the safety of your therapeutic programs with these comprehensive assessments. |
|
|
|
Webinar | Invetech | AI is transforming cell therapy manufacturing and enabling more personalized treatments. Explore how to navigate innovation in a fast-moving therapeutic landscape with actionable insights. |
|
|
|
Webinar | Lonza | Long-term contract manufacturing partnerships play a vital role in commercial success. Review real-world insights from a ten-year collaboration that successfully brought therapies to market. |
|
|
|
Video | Cell & Gene | Industry experts outline strategies for validating residual impurity removal in allogeneic therapies, from early research through GMP production, to satisfy rigorous regulatory standards. |
|
|
|
Video | Cell & Gene | Episode 134 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Shannon Boye, PhD, Founder and CSO of Atsena Therapeutics. Dr. Boye shares how the company is approaching Stargardt disease with a differentiated gene therapy strategy built around delivery, dual-vector design, and a disciplined go/no-go framework. |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
